Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-23

Clinical Trial Update: Study of ARO-CFB in Adult Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study of ARO-CFB in healthy adult volunteers for an IgA Nephropathy program; the trial is currently active but not recruiting, sponsored by Arrowhead Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARO-CFB

Snippet

Sponsor: Arrowhead Pharmaceuticals | Conditions: IgA Nephropathy | Phase 1 | Status: ACTIVE_NOT_RECRUITING